Francesco Isaia Selected Research

bis(1,10-phenanthroline)copper(2+) ion

1/2020	The first copper(ii) complex with 1,10-phenanthroline and salubrinal with interesting biochemical properties.
1/2017	Competitive reactions among glutathione, cisplatin and copper-phenanthroline complexes.
10/2015	Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.
9/2012	Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Francesco Isaia Research Topics

Disease

5	Neoplasms (Cancer) 02/2019 - 09/2012
3	Carcinoma (Carcinomatosis) 02/2019 - 09/2012
2	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 04/2014
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013
1	Leukemia 09/2012
1	Scrapie 03/2011
1	Neuroblastoma 03/2011

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 02/2019 - 10/2013
4	bis(1,10-phenanthroline)copper(2+) ionIBA 01/2020 - 09/2012
2	Glutathione (Reduced Glutathione)IBA 02/2019 - 09/2012
2	Antineoplastic Agents (Antineoplastics)IBA 04/2014 - 09/2012
1	salubrinalIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 02/2019
1	LipidsIBA 01/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2017
1	MetalsIBA 10/2015
1	2-(2'-pyridyl)benzimidazoleIBA 04/2014
1	salicylhydroxamic acid (SHAM)IBA 04/2014
1	GoldIBA 04/2014
1	LigandsIBA 04/2014
1	ThionesIBA 10/2013
1	ImidazolidinesIBA 10/2013
1	CopperIBA 03/2011
1	Prion ProteinsIBA 03/2011

Therapy/Procedure

1	Therapeutics 01/2019